Corteva, Inc. Non-GAAP EPS of $0.06 misses by $0.04, revenue of $1.59B misses by $180M (NYSE:CTVA)

Corteva, Inc. reported Q3 Non-GAAP EPS of $0.06, missing estimates by $0.04, with revenue of $1.59B, down 8.6% year-over-year and $180M below expectations. The company attributed the shortfall to lower-than-anticipated demand in certain markets.

Original reporting
Published Nov 11, 2026, 9:32 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 11, 2026, 9:35 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$CTVA
Bearish
high confidence
Mentioned
$CTVA
Relevance
7/10
AlphAI data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$CTVABearishMed
01

Why it matters

The miss on both earnings and revenue is likely to drive a short‑term decline in CTVA shares, with possible spillover to the broader agriscience sector.

02

Market read

First‑report earnings miss for a mid‑cap U.S. listed company; immediate relevance for traders.

03

What to watch

Potential cost‑saving initiatives and upcoming product launches may mitigate the impact of the miss.

Relevance 7/10Novelty 7/10Timing: after-hours today

Background

Corteva's Q3 earnings release was posted on its investor website and picked up by Seeking Alpha.

Company-level read

Ticker impact

$CTVABearishHigh confidence
Context

Corteva reported Q3 Non-GAAP EPS of $0.06, missing expectations by $0.04 and revenue of $1.59B, missing by $180M.

Expected impact

likely pressure as the market prices in the earnings miss

Evidence & confidence

Both EPS and revenue fell short of consensus, a material miss for a mid‑cap agriscience company.

Market effects

Agricultural chemicals sector may see broader pressure as peers' earnings expectations are reassessed.

U.S. market may see modest pullback in related agribusiness stocks.

Limited to U.S. and global agriscience investors.

Counterpoint

If Corteva's miss is viewed as a temporary setback, the stock could rebound on longer‑term growth prospects.

Key entities

  • Corteva, Inc.

    U.S. agriscience company reporting Q3 results.

Related articles

$CTVAHighAI 8/10

Corteva Reports Third-Quarter 2026 Results; Updates FY 2026 Outlook

Corteva, Inc. (CTVA) filed an SEC Form 8-K — Results of Operations and Financial Condition. News Release Corteva Reports Third-Quarter 2026 Results; Updates FY 2026 Outlook • Third-quarter results reflect strong new product sales growth and continued operational excellence, helping mitigate broader market headwinds • Pricing pressure was concentrated in North America an

$CTVAMed

Mizuho reiterates Corteva stock rating on challenging crop market

Mizuho reiterated an Outperform rating and $16.00 price target for Corteva Inc. (CTVA) after its latest results. The stock is undervalued at $12.14, with a market cap of $8.1 billion. Corteva reported a 17% YoY decline in EBITDA, with regional sales varying. The company reduced its 2026 EBITDA guidance due to challenging market conditions, particularly in Brazil. Q3 results missed expectations, with revenue down 9% YoY.

$CTVAHighAI 8/10

Corteva shares fall 6% on worse-than-expected Q3 results

Corteva Inc. (CTVA) reported Q3 earnings of $0.06 per share, missing estimates of $0.10, and revenue of $1.59B, below the $1.77B forecast. Shares fell 6.4%. Full-year 2026 guidance adjusted, with EPS midpoint at $0.78, above consensus, but EBITDA guidance lowered due to Brazil market conditions. Revenue declined 9% YoY, with Latin America sales down 31% and North America up 7%.

$CTVAHighAI 8/10

Why is Corteva stock sliding today?

Corteva stock fell 6.4% after reporting Q3 results below expectations, with net sales down 9% YoY and a GAAP loss of $54M. Adjusted EPS dropped 57% to $0.06. The company cited weak Latin America performance and revised 2026 guidance lower, citing Brazil market conditions. Analysts had already cut EPS estimates and price targets. The S&P 500 was flat, indicating the drop was company-specific.

$CTVAHighAI 8/10

Corteva Reports Third-Quarter 2026 Results; Updates FY 2026 Outlook

Corteva reported Q3 2026 results with net sales down 9% YoY to $1.59B, organic sales also down 9%. Adjusted EBITDA fell 17% to $222M. Full-year guidance was updated, reflecting weaker Brazil market conditions, with adjusted EBITDA now expected between $1.1B and $1.125B. CEO Luke Kissam cited strong new product performance and operational excellence.